Heart Disease Clinical Trials in Nashville

Showing 301-320 of 431 trials

High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)

NCT02592135

The purpose of this study is to better understand myocardial injury in AHF. Secondary analyses demonstrate the prognostic significance of troponin release. The absence of such release has been associated with less risk. Whether measurement of high sensitivity TnT may enable emergency physicians to better risk stratify acute heart failure patients remains to be determined. This study will help us to better understand the prognostic value of absent or low hsTnT values in the emergency department setting. In addition, we will also test the STRATIFY decision rule; a risk score.

Heart Failure

Indiana University500 participantsStarted Dec 2015

Indianapolis, Indiana, United States • Indianapolis, Indiana, United States • Detroit, Michigan, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

NCT00088179

During a heart bypass procedure, a substance called "complement" is activated by the body. This "complement activation" causes an inflammatory response that can lead to side affects such as chest pain, heart attacks, stroke, heart failure, or death. The purpose of this study is to find out if the study drug (pexelizumab), that blocks "complement activation," can reduce such side effects and be given safely to patients requiring the bypass procedure with the use of the heart-lung machine.

Coronary Artery Disease

Alexion Pharmaceuticals, Inc.4,000 participantsStarted Jul 2004

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +185 more locations

High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Heart Disease Trials in Other Cities

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients

A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

The BOSS Study: An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS)

Vascular Inflammation in Psoriasis - Extension Study

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Other Conditions in Nashville